BioSpace News Archive

Correvio Pharma Corp. announced it has resubmitted a New Drug Application to the U.S. Food and Drug Administration seeking approval for Brinavess™, its antiarrhythmic drug for the rapid conversion of adult patients with recent onset atrial fibrillation.

Social media and news aggregation site will highlight real-time digital conversations at DIA 2019

Technavio’s latest market research report on the global thoracic surgery market predicts the market to witness a CAGR of over 9% during the forecast period.

Rimegepant leads the meeting with the most presentations for an oral small molecule CGRP receptor antagonist, including 14 late breakers

The Detroit Tigers will continue its tradition of uniting our community to encourage breast health awareness at the eighth annual Pink Out the Park on Friday, July 19, when the Tigers face the Toronto Blue Jays at Comerica Park.

Magnetic muscle stimulation technology to strengthen, tone and firm muscles

Catalent, Inc. announced that its wholly owned subsidiary, Catalent Pharma Solutions, Inc., intends to offer, subject to market and other conditions, $500 million in aggregate principal amount of senior unsecured notes due 2027 in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended.

Speakers to include Katie Couric, St. Jude leader James R. Downing, M.D., Global Health Innovator Thomas F. Burke, M.D., Harvard Nutrition Professor Walter Willett, M.D., Former Health Minister of Rwanda Agnes Binagwaho, M.D. and Theranos Whistleblowers Tyler Shultz and Erika Cheung

Navidea Biopharmaceuticals, Inc., a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, is pleased to announce that the results of the Company’s NAV3-21 clinical study at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Anaheim, CA have been highlighted with a press release by the SNMMI.

Epilepsy Foundation, the largest national epilepsy advocacy organization, has selected the team of Prometheus Research and HealthVerity to develop a new data infrastructure capable of creating the largest hub of repurposable data on epilepsy in the world.